1
Views
0
CrossRef citations to date
0
Altmetric
Research Article

HTLV-I-associated myelopathy: Are ferritin, S100β protein, or guanine nucleotides CSF markers of disease?

Pages 64-67 | Published online: 10 Jul 2009

References

  • All A, Rudge P, Dalgleish AG (1992). Neopterin concen-trations in serum and cerebrospinal fluid in HTLV-I in-fected individuals. J Neurol 239: 270–272.
  • Ferreira OC Jr, Vaz RS, Carvalho MB, Guerra C, Fabron AL, Rosemblit J, Hamerschlak N (1995). Human T-lymphotropic virus type I and type II infections and correlation with risk factors in blood donors from Silo Paulo, Brazil. Transfusion 35: 258–263.
  • Gessain A, Gout 0 (1992). Chronic myelopathy associated with human T-lymphotropic virus type I (HTLV-I). Ann Intern Med 117: 933–946.
  • Green AJ, Harvey RJ, Thompson EJ, et al. (1997). Increased S100beta in the cerebrospinal fluid of patient with fron-totemporal dementia. Neurosci Lett 10: 235.
  • Griffin DE, McArthur J, Comblath DR (1991). Neopterin and interferon-gamma in serum and cerebrospinal fluid of patients with HIV-associated neurologic disease. Neurology 41: 69–75.
  • Hall WW, Ishak R, Zhu SW, et al. (1996). Human T lym-photropic virus, type II (HTLV-II): epidemiology, molec-ular properties, and clinical features of infection. J AIDS Hum Retroviro113(Suppl 1): S204–S214.
  • Hooper DC, Scott GS, Zboreck A, et al. (2000). Uric acid, a peroxynitrite scavenger, inhibits CNS inflammation blood-CNS barrier permeability changes, and tissue damage in a mouse model of multiple sclerosis. FASEB J14: 691–698.
  • Ingebrigtsen T, Waterloo K, Jacobsen EA, et al. (1999). Traumatic brain damage in minor head injury: rela-tion of serum S-100 protein measurements to mag-netic resonance imaging and neurobehavior outcome. Neurosurgery 45: 468–475.
  • Kurtzke JF (1983). Rating neurologic impairment in multi-ple sclerosis: an expanded disability status scale (EDSS). Neurology 33: 1444–1452.
  • Malcon C, Achaval M, Komlos F, et al. (1997). GMP pro-tects against quinolinic acid-induced loss of NADPH-diaphorase-positive cells in the rat striatum. Neurosci Lett 225: 145–148.
  • Menna-Barreto M, Doval A, Rabolini G, Bianchini 0 (1995). HTLV-I associated myelophathy in Porto Alegre (southern Brazil). Arq Neuropsiquiatr 53: 771–776.
  • Menna-Barreto M (1996). HTLV-I-II Neurological diseases in Porto Alegre (Southern Brazil). In: HTLV: truths and Questions. 1st ed. Zaninovic V (ed). Cali (Colombia): Fundacion Mar, pp 131–139.
  • Milman N, Graudal NA, Olsen TS, et al. (1993). Cere-brospinal fluid ferritin in patients with meningitis and cerebral infarction or bleeding. Dan Med Bull 40: 490–492.
  • Nagai M, Usuku K, Matsumoto W (1998). Analysis of HTLV-I proviral load in 202 HAM/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM/TSP. I NeuroVirol 4: 586–593.
  • Nomoto M, Utatsu Y, Soejima Y (1991). Neopterin in cere-brospinal fluid: a useful marker for diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis. Neurology 41: 457.
  • Osame M (1990). Review of WHO Kagoshima meeting and diagnostic guidelines for HAM/TSP. In: Human Retrovi-rology: HTLV. 1st ed. Blattner W (ed.). Raven Press: New York, pp 191–197.
  • Regner A, Crestana RE, Silveira F JP, Friedman G, Chemale I, Souza D (1997). Guanine nucleotides are present in human CSF. NeuroReport 8: 3771–3774.
  • Regner A, Kaufman M, Friedman G, Chemale I (2001). Increased serum S100 beta protein concentrations fol-lowing severe head injury in humans: a biochem-ical marker of brain death? NeuroReport 12: 691–694.
  • Regner A, Ramirez G, Belló-Klein A, Souza D (1998). Ef-fects of guanine nucleotides on glutamate-induced chemiluminescence in rat hippocampal slices submitted to hypoxia. Neurochem Res 23: 523–528.
  • Schmidt AP, Lara DR, Maraschin JF, da Silveira Perla A, Onofre Souza D (2000). Guanosine and GMP prevent seizuresm induced by quinolinic acid in mice. Brain Res 864: 40–43.
  • Sindic CJM, Collet-Cassart D, Cambiaso CL, et al. (1981). The clinical relevance of ferritin concentration in the cerebrospinal fluid. I Neurol Neurosurg Psychiatry 44: 329–333.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.